Peer-review started: June 1, 2018
First decision: June 5, 2018
Revised: June 28, 2018
Accepted: June 30, 2018
Article in press: June 30, 2018
Published online: August 7, 2018
Processing time: 67 Days and 17.7 Hours
We reported a human immunodeficiency virus (HIV) infected patient in remission with antiretroviral therapy (ART), who presented with a rare tip variant of focal segmental glomerulosclerosis (FSGS), which resolved with corticosteroid therapy.
We diagnosed the patient as a case of HIV infection presenting as a tip variant of FSGS.
HIV-associated nephropathy (HIVAN) or other causes of FSGS have to be differentiated because therapeutic strategies (ART or steroids) are different.
Whether HIV RNA levels are positive or negative are important.
Tip variant of FSGS is needed to diagnose that more than one glomerulus show epithelial hypercellularity at the tubular pole, where a confluence of the tubular cells at the tubular outlet is observed in renal biopsy specimen.
Steroid therapy is considered to administer to other causes of FSGS except for HIVAN including the tip variant.
Lescure et al is important for the readers to understand the changes of HIV-associated kidney glomerular diseases with time and ART.
Tip variant is one of the diagnoses in the Columbia classification of FSGS and is explained as follows: More than one glomerulus shows epithelial hypercellularity at the tubular pole, where a confluence of the tubular cells at the tubular outlet is observed in renal biopsy.
When renal damage is caused in HIV-infected patients, a renal biopsy may be essential to determine the renal histology and to decide on corticosteroid therapy.
